Hi, what are you looking for?
– CEO Dr. Pnina Fishman Can-Fite BioPharma Ltd. (NYSE MKT: CANF), (TASE: CFBI), CEO Dr. Pnina Fishman will ring The Opening Bell at the...
– The cancer and inflammatory drug development company will list its Level II ADRs on the NYSE MKT on Tuesday , November 19, 2013...
– Can-Fite will use the proceeds to increase its shareholders’ equity to meet the criteria for listing its ADRs on the NYSE. – Can-Fite...
– Can-Fite Ceo Pnina Fishman – /By Ilan Shavit/ Can-Fite BioPharma Ltd. (TASE:CFBI; Bulletin Board: CANFY) has obtained a patent from the US Patent and...
They don’t call Israel Startup Nation for nothing. Here is a list of stories from the country’s high tech sector from this past week....
In the 20th Sep 2015 edition of Israel’s good news, the highlights include: · South Africa has chosen an Israeli system to screen...
– Discount Investment and IDB Development are sharply down in an otherwise stable market. – Following the cancellation by Adama Holding Ltd. (TASE:ADMA.B1) of...
– In the 5th Jan 2014 edition of Israel’s good news: ECONOMY & BUSINESS Matchmakers bring Dutch and Israelis together. “Matchmaking @ Netherlands-Israel...
UK based Edison Investment Research, which describes itself as an “investment intelligence company”, has just announced it has extended the company’s presence to Israel...
– Can-Fite BioPharma Ltd. (TASE: CFBI), (OTCQB: CANFY) and its subsidiary, OphthaliX Inc. (OTCQB: OPLI), jointly announced today that the U.S. Patent and Trademark Office...